IBDEI1XN ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33947,1,4,0)
 ;;=4^I69.354
 ;;^UTILITY(U,$J,358.3,33947,2)
 ;;=^5007507
 ;;^UTILITY(U,$J,358.3,33948,0)
 ;;=I69.151^^183^2013^44
 ;;^UTILITY(U,$J,358.3,33948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33948,1,3,0)
 ;;=3^Hemiplga fol ntrm intcrbl hemor aff right dominant side
 ;;^UTILITY(U,$J,358.3,33948,1,4,0)
 ;;=4^I69.151
 ;;^UTILITY(U,$J,358.3,33948,2)
 ;;=^5007441
 ;;^UTILITY(U,$J,358.3,33949,0)
 ;;=I69.152^^183^2013^42
 ;;^UTILITY(U,$J,358.3,33949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33949,1,3,0)
 ;;=3^Hemiplga fol ntrm intcrbl hemor aff left dominant side
 ;;^UTILITY(U,$J,358.3,33949,1,4,0)
 ;;=4^I69.152
 ;;^UTILITY(U,$J,358.3,33949,2)
 ;;=^5007442
 ;;^UTILITY(U,$J,358.3,33950,0)
 ;;=I69.153^^183^2013^45
 ;;^UTILITY(U,$J,358.3,33950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33950,1,3,0)
 ;;=3^Hemiplga fol ntrm intcrbl hemor aff right nondom side
 ;;^UTILITY(U,$J,358.3,33950,1,4,0)
 ;;=4^I69.153
 ;;^UTILITY(U,$J,358.3,33950,2)
 ;;=^5007443
 ;;^UTILITY(U,$J,358.3,33951,0)
 ;;=I69.154^^183^2013^43
 ;;^UTILITY(U,$J,358.3,33951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33951,1,3,0)
 ;;=3^Hemiplga fol ntrm intcrbl hemor aff left nondom side
 ;;^UTILITY(U,$J,358.3,33951,1,4,0)
 ;;=4^I69.154
 ;;^UTILITY(U,$J,358.3,33951,2)
 ;;=^5007444
 ;;^UTILITY(U,$J,358.3,33952,0)
 ;;=I69.851^^183^2013^50
 ;;^UTILITY(U,$J,358.3,33952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33952,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff right dominant side
 ;;^UTILITY(U,$J,358.3,33952,1,4,0)
 ;;=4^I69.851
 ;;^UTILITY(U,$J,358.3,33952,2)
 ;;=^5007535
 ;;^UTILITY(U,$J,358.3,33953,0)
 ;;=I69.852^^183^2013^51
 ;;^UTILITY(U,$J,358.3,33953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33953,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff left dominant side
 ;;^UTILITY(U,$J,358.3,33953,1,4,0)
 ;;=4^I69.852
 ;;^UTILITY(U,$J,358.3,33953,2)
 ;;=^5007536
 ;;^UTILITY(U,$J,358.3,33954,0)
 ;;=I69.853^^183^2013^52
 ;;^UTILITY(U,$J,358.3,33954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33954,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff right nondom side
 ;;^UTILITY(U,$J,358.3,33954,1,4,0)
 ;;=4^I69.853
 ;;^UTILITY(U,$J,358.3,33954,2)
 ;;=^5007537
 ;;^UTILITY(U,$J,358.3,33955,0)
 ;;=I69.854^^183^2013^53
 ;;^UTILITY(U,$J,358.3,33955,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33955,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff left nondom side
 ;;^UTILITY(U,$J,358.3,33955,1,4,0)
 ;;=4^I69.854
 ;;^UTILITY(U,$J,358.3,33955,2)
 ;;=^5007538
 ;;^UTILITY(U,$J,358.3,33956,0)
 ;;=I69.251^^183^2013^54
 ;;^UTILITY(U,$J,358.3,33956,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33956,1,3,0)
 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff right dominant side
 ;;^UTILITY(U,$J,358.3,33956,1,4,0)
 ;;=4^I69.251
 ;;^UTILITY(U,$J,358.3,33956,2)
 ;;=^5007473
 ;;^UTILITY(U,$J,358.3,33957,0)
 ;;=I69.252^^183^2013^55
 ;;^UTILITY(U,$J,358.3,33957,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33957,1,3,0)
 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff left dominant side
 ;;^UTILITY(U,$J,358.3,33957,1,4,0)
 ;;=4^I69.252
 ;;^UTILITY(U,$J,358.3,33957,2)
 ;;=^5007474
 ;;^UTILITY(U,$J,358.3,33958,0)
 ;;=I69.253^^183^2013^56
 ;;^UTILITY(U,$J,358.3,33958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33958,1,3,0)
 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff right nondom side
 ;;^UTILITY(U,$J,358.3,33958,1,4,0)
 ;;=4^I69.253
 ;;^UTILITY(U,$J,358.3,33958,2)
 ;;=^5007475
 ;;^UTILITY(U,$J,358.3,33959,0)
 ;;=I69.254^^183^2013^57
 ;;^UTILITY(U,$J,358.3,33959,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33959,1,3,0)
 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff left nondom side
 ;;
 ;;$END ROU IBDEI1XN
